Neuronal caspase-3 signaling: Not only cell death

Cell Death and Differentiation

Volumn 17, Issue 7, 2010, Pages 1104-1114

  D'Amelio, M ^a,b   Cavallucci, V ^a,b   Cecconi, F ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Apoptosis; Neurodegeneration; Neurodevelopment; Neuron differentiation; Synaptic plasticity

Indexed keywords

ADAPTOR PROTEIN; AMYLOID BETA PROTEIN; APOPTOSOME; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BETA SECRETASE; CASPASE 3; CASPASE 6; CASPASE 9; COPPER ZINC SUPEROXIDE DISMUTASE; CULLIN; CULLIN 3; CYTOCHROME C; DEATH RECEPTOR; DEATH RECEPTOR 6; HUNTINGTIN; PARKIN; POLYGLUTAMINE; PRESENILIN; PROTEIN BCL 2; PROTEIN GGA3; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BRAIN DEVELOPMENT; BRAIN ISCHEMIA; BRAIN MALFORMATION; DEGENERATIVE DISEASE; DENDRITE; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; LEARNING; LONG TERM POTENTIATION; MEMORY; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; ANIMAL; CYTOLOGY; ENZYMOLOGY; GENE INACTIVATION; GENETICS; METABOLISM; MOUSE; NERVE CELL; NERVOUS SYSTEM DISEASES; PHYSIOLOGY; RAT;

ANIMALS; APOPTOSIS; CASPASE 3; GENE KNOCKOUT TECHNIQUES; MICE; NERVOUS SYSTEM DISEASES; NEURONAL PLASTICITY; NEURONS; RATS; SIGNAL TRANSDUCTION;

GASTROPODA; RATTUS;

EID: 77953613803     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2009.180     Document Type: Review

References (87)

1. Nicholson DW, Thornberry NA. Apoptosis. Life and death decisions. Science 2003; 299: 214-215.
2. Creagh EM, Martin SJ. Caspases: cellular demolition experts. Biochem Soc Trans 2001; 29: 696-702.
3. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999; 68: 383-424.
4. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004; 305: 626-629.
5. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME. Apoptosis signaling by death receptors. Eur J Biochem 1998; 254: 439-459.
6. Er E, Oliver L, Cartron PF, Juin P, Manon S, Vallette FM. Mitochondria as the target of the pro-apoptotic protein Bax. Biochim Biophys Acta 2006; 1757: 1301-1311.
7. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007; 87: 99-163. (Pubitemid 46209992)
8. Labi V, Erlacher M, Kiessling S, Villunger A. BH3-only proteins in cell death initiation, malignant disease and anticancer therapy. Cell Death Differ 2006; 13: 1325-1338.
9. Roy S, Nicholson DW. Cross-talk in cell death signaling. J Exp Med 2000; 192: F21-F25.
10. Degterev A, Yuan J. Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol 2008; 9: 378-390.
11. Lettre G, Hengartner MO. Developmental apoptosis in C. elegans: a complex CEDnario. Nat Rev Mol Cell Biol 2006; 7: 97-108.
12. Jagasia R, Grote P, Westermann B, Conradt B. DRP-1-mediated mitochondrial fragmentation during EGL-1-induced cell death in C. elegans. Nature 2005; 433: 754-760.
13. Yu X, Wang L, Acehan D, Wang X, Akey CW. Three-dimensional structure of a double apoptosome formed by the Drosophila Apaf-1 related killer. J Mol Biol 2006; 355: 577-589.
14. Vaux DL, Silke J. IAPs-the ubiquitin connection. Cell Death Differ 2005; 12: 1205-1207.
15. Arama E, Agapite J, Steller H. Caspase activity and a specific cytochrome C are required for sperm differentiation in Drosophila. Dev Cell 2003; 4: 687-697.
16. Arama E, Bader M, Srivastava M, Bergmann A, Steller H. The two Drosophila cytochrome C proteins can function in both respiration and caspase activation. EMBO J 2006; 25: 232-243.
17. Burek M, Oppenheim R. Cellular interactions that regulate programmed cell death in the developing vertebrate nervous system. In: Koliatsos V, Ratan R (eds). Cell Death and Disease of the Nervous System. Humana: Totowa, 1999, pp 145-180.
18. Mazarakis ND, Edwards AD, Mehmet H. Apoptosis in neural development and disease. Arch Dis Child 1997; 77: F165-F170.
19. Raoul C, Henderson CE, Pettmann B. Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J Cell Biol 1999; 147: 1049-1062.
20. Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J et al. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducingligand mediate ischemia-induced apoptosis in neurons. J Neurosci 1999; 19: 3809-3817.
21. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384: 368-372.
22. Leonard JR, Klocke BJ, D'Sa C, Flavell RA, Roth KA. Strain-dependent neuro-developmental abnormalities in caspase-3-deficient mice. J Neuropathol Exp Neurol 2002; 61: 673-677.
23. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998; 94: 339-352.
24. Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Karasuyama H et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998; 94: 325-337.
25. Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA, Gruss P. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 1998; 94: 727-737.
26. Hao Z, Duncan GS, Chang CC, Elia A, Fang M, Wakeham A et al. Specific ablation of the apoptotic functions of cytochrome C reveals a differential requirement for cytochrome C and Apaf-1 in apoptosis. Cell 2005; 121: 579-591.
27. Zermati Y, Mouhamad S, Stergiou L, Besse B, Galluzzi L, Boehrer S et al. Nonapoptotic role for Apaf-1 in the DNA damage checkpoint. Mol Cell 2007; 28: 624-637.
28. Clarke PG. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl) 1990; 181: 195-213.
29. Zaidi AU, McDonough JS, Klocke BJ, Latham CB, Korsmeyer SJ, Flavell RA et al. Chloroquine-induced neuronal cell death is p53 and Bcl-2 family-dependent but caspase-independent. J Neuropathol Exp Neurol 2001; 60: 937-945.
30. Fernando P, Brunette S, Megeney LA. Neural stem cell differentiation is dependent upon endogenous caspase 3 activity. FASEB J 2005; 19: 1671-1673.
31. Luo L, O'Leary DD. Axon retraction and degeneration in development and disease. Annu Rev Neurosci 2005; 28: 127-156.
32. Truman JW. Metamorphosis of the central nervous system of Drosophila. J Neurobiol 1990; 21: 1072-1084.
33. Williams DW, Kondo S, Krzyzanowska A, Hiromi Y, Truman JW. Local caspase activity directs engulfment of dendrites during pruning. Nat Neurosci 2006; 9: 1234-1236.
34. Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009; 457: 981-989.
35. Chan SL, Mattson MP. Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res 1999; 58: 167-190.
36. Dash PK, Blum S, Moore AN. Caspase activity plays an essential role in long-term memory. Neuroreport 2000; 11: 2811-2816.
37. Mattson MP, Keller JN, Begley JG. Evidence for synaptic apoptosis. Exp Neurol 1998; 153: 35-48.
38. Bravarenko NI, Onufriev MV, Stepanichev MY, Ierusalimsky VN, Balaban PM, Gulyaeva NV. Caspase-like activity is essential for long-term synaptic plasticity in the terrestrial snail Helix. Eur J Neurosci 2006; 23: 129-140.
39. Huesmann GR, Clayton DF. Dynamic role of postsynaptic caspase-3 and BIRC4 in zebra finch song-response habituation. Neuron 2006; 52: 1061-1072.
40. Stepanichev MY, Kudryashova IV, Yakovlev AA, Onufriev MV, Khaspekov LG, Lyzhin AA et al. Central administration of a caspase inhibitor impairs shuttle-box performance in rats. Neuroscience 2005; 136: 579-591.
41. Gulyaeva NV, Kudryashov IE, Kudryashova IV. Caspase activity is essential for long-term potentiation. J Neurosci Res 2003; 73: 853-864.
42. Guo ZH, Mattson MP. Neurotrophic factors protect cortical synaptic terminals against amyloid and oxidative stress-induced impairment of glucose transport, glutamate transport and mitochondrial function. Cereb Cortex 2000; 10: 50-57.
43. Arama E, Bader M, Rieckhof GE, Steller H. A ubiquitin ligase complex regulates caspase activation during sperm differentiation in Drosophila. PLoS Biol 2007; 5: e251.
44. Choi DW. Calcium and excitotoxic neuronal injury. Ann N Y Acad Sci 1994; 747: 162-171.
45. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 1982; 11: 491-498.
46. Loddick SA, MacKenzie A, Rothwell NJ. An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat. Neuroreport 1996; 7: 1465-1468.
47. Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z et al. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 1997; 94: 2007-2012.
48. Schielke GP, Yang GY, Shivers BD, Betz AL. Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J Cereb Blood Flow Metab 1998; 18: 180-185.
49. Chen J, Nagayama T, Jin K, Stetler RA, Zhu RL, Graham SH et al. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 1998; 18: 4914-4928.
50. Himi T, Ishizaki Y, Murota S. A caspase inhibitor blocks ischaemia-induced delayed neuronal death in the gerbil. Eur J Neurosci 1998; 10: 777-781.
51. Cheng Y, Deshmukh M, D'Costa A, Demaro JA, Gidday JM, Shah A et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 1998; 101: 1992-1999.
52. Kawas CH. Clinical practice. Early Alzheimer's disease. N Engl J Med 2003; 349: 1056-1063.
53. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81: 741-766.
54. Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K et al. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 1995; 89: 35-41.
55. Su JH, Anderson AJ, Cummings BJ, Cotman CW. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 1994; 5: 2529-2533.
56. Smale G, Nichols NR, Brady DR, Finch CE, Horton Jr WE. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 1995; 133: 225-230.
57. Kim TW, Pettingell WH, Jung YK, Kovacs DM, Tanzi RE. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 1997; 277: 373-376.
58. Loetscher H, Deuschle U, Brockhaus M, Reinhardt D, Nelboeck P, Mous J et al. Presenilins are processed by caspase-type proteases. J Biol Chem 1997; 272: 20655-20659.
59. Brockhaus M, Grünberg J, Röhrig S, Loetscher H, Wittenburg N, Baumeister R et al. Caspase-mediated cleavage is not required for the activity of presenilins in amyloidogenesis and NOTCH signaling. Neuroreport 1998; 9: 1481-1486.
60. Tesco G, Koh YH, Kang EL, Cameron AN, Das S, Sena-Esteves M et al. Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron 2007; 54: 721-737.
61. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-133.
62. Buratti E, Brindisi A, Pagani F, Baralle FE. Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance. Am J Hum Genet 2004; 74: 1322-1325.
63. Rohn TT. Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease. Brain Res 2008; 1228: 189-198.
64. Louneva N, Cohen JW, Han LY, Talbot K, Wilson RS, Bennett DA et al. Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease. Am J Pathol 2008; 173: 1488-1495.
65. Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ. Synaptic alterations in CA1 in mild Alzheimer's disease and mild cognitive impairment. Neurology 2007; 68: 1501-1508.
66. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008; 79: 368-376.
67. Mochizuki H, Goto K, Mori H, Mizuno Y. Histochemical detection of apoptosis in Parkinson's disease. J Neurol Sci 1996; 137: 120-123.
68. Hirsch EC, Hunot S, Faucheux B, Agid Y, Mizuno Y, Mochizuki H et al. Dopaminergic neurons degenerate by apoptosis in Parkinson's disease. Mov Disord 1999; 14: 383-385.
69. Banati RB, Daniel SE, Blunt SB. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov Disord 1998; 13: 221-227.
70. Hartmann A, Hunot S, Michel PP, Muriel MP, Vyas S, Faucheux BA et al. Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci USA 2000; 97: 2875-2880.
71. Kahns S, Lykkebo S, Jakobsen LD, Nielsen MS, Jensen PH. Caspase-mediated parkin cleavage in apoptotic cell death. Biol Chem 2002; 277: 15303-15308.
72. Walker FO. Huntington's disease. Lancet 2007; 369: 218-228.
73. Dragunow M, Faull RL, Lawlor P, Beilharz EJ, Singleton K, Walker EB et al. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 1995; 6: 1053-1057.
74. Warrick JM, Paulson HL, Gray-Board GL, Bui QT, Fischbeck KH, Pittman RN et al. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 1998; 93: 939-949.
75. Toulmond S, Tang K, Bureau Y, Ashdown H, Degen S, O'Donnell R et al. Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease. Br J Pharmacol 2004; 141: 689-697.
76. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001; 344: 1688-1700.
77. Li M, Ona VO, Guégan C, Chen M, Jackson-Lewis V, Andrews LJ et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 2000; 288: 335-339.
78. Pasinelli P, Houseweart MK, Brown Jr RH, Cleveland DW. Caspase-1 and-3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 2000; 97: 13901-13906.
79. Guégan C, Vila M, Rosoklija G, Hays AP, Przedborski S. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J Neurosci 2001; 21: 6569-6576.
80. Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M, Przedborski S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 1997; 277: 559-562. (Pubitemid 27369003)
81. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002; 417: 74-78.
82. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43-50.
83. Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol 2001; 3: 339-345.
84. Ura S, Masuyama N, Graves JD, Gotoh Y. Caspase cleavage of MST1 promotes nuclear translocation and chromatin condensation. Proc Natl Acad Sci USA 2001; 98: 10148-10153.
85. Rosen A, Casciola-Rosen L. Macromolecular substrates for the ICE-like proteases during apoptosis. J Cell Biochem 1997; 64: 50-54.
86. Lüthi AU, Martin SJ. The CASBAH: a searchable database of caspase substrates. Cell Death Differ 2007; 14: 641-650.
87. Cecconi F, Piacentini M, Fimia GM. The involvement of cell death and survival in neural tube defects: a distinct role for apoptosis and autophagy? Cell Death Differ 2008; 15: 1170-1177.